PF-06647263

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06647263, covering 2019-04-29 to 2019-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-06647263 In Patients With Advanced Solid Tumors [Phase 1]